Stockreport

Allena Pharmaceuticals to Present New Data on Reloxaliase and ALLN-346 Development Programs at Upcoming ASN Kidney Week and ACR/ARP Annual Meeting

Allena Pharmaceuticals, Inc.  (ALNA) 
Last allena pharmaceuticals, inc. earnings: 3/16 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.allenapharma.com/investor-relations
PDF NEWTON, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and comme [Read more]